SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,449,342 | -10.5% | 149,193 | +1.5% | 0.00% | 0.0% |
Q2 2023 | $3,855,467 | +173101.6% | 147,043 | +70.1% | 0.00% | 0.0% |
Q1 2023 | $2,226 | -9.7% | 86,470 | -8.7% | 0.00% | 0.0% |
Q4 2022 | $2,465 | -99.9% | 94,752 | -14.4% | 0.00% | 0.0% |
Q3 2022 | $3,159,000 | +14.6% | 110,716 | -1.1% | 0.00% | 0.0% |
Q2 2022 | $2,756,000 | -53.1% | 111,924 | +14.1% | 0.00% | -50.0% |
Q1 2022 | $5,881,000 | -19.9% | 98,053 | -10.6% | 0.00% | 0.0% |
Q4 2021 | $7,339,000 | -17.5% | 109,710 | -7.8% | 0.00% | -33.3% |
Q3 2021 | $8,896,000 | -33.6% | 118,943 | -26.8% | 0.00% | -25.0% |
Q2 2021 | $13,393,000 | +95.7% | 162,521 | +74.8% | 0.00% | +100.0% |
Q1 2021 | $6,842,000 | -9.7% | 93,000 | -11.0% | 0.00% | -33.3% |
Q4 2020 | $7,580,000 | +83.0% | 104,534 | +20.3% | 0.00% | +50.0% |
Q3 2020 | $4,142,000 | +13.3% | 86,899 | -0.2% | 0.00% | +100.0% |
Q2 2020 | $3,657,000 | +216.9% | 87,075 | +103.7% | 0.00% | 0.0% |
Q1 2020 | $1,154,000 | -19.5% | 42,742 | +14.8% | 0.00% | 0.0% |
Q4 2019 | $1,433,000 | – | 37,240 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |